A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM
NCT05088330
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
76
Enrollment
OTHER
Sponsor class
Conditions
Newly Diagnosed Multiple Myeloma
Interventions
DRUG:
Daratumumab
Sponsor
The First Affiliated Hospital of Soochow University